Stem Cell Therapy Potentially Could Treat Type 1 Diabetes by Helping Patients Produce Insulin

November 29, 2021

(USA Today) – Stem cell-derived therapy may be an avenue for treating Type 1 diabetes, according to a clinical trial by Vertex Pharmaceuticals. The trial was centered on one patient, who was diagnosed with Type 1 diabetes 40 years ago. For decades, he had been dependent on insulin injections to manage his blood sugar. (Read More)